Search Results (32)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. | Academic Article |
Why?
|
| Rapid modelling of cooperating genetic events in cancer through somatic genome editing. | Academic Article |
Why?
|
| CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems. | Academic Article |
Why?
|
| Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses. | Academic Article |
Why?
|
| A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. | Academic Article |
Why?
|
| NmeCas9 is an intrinsically high-fidelity genome-editing platform. | Academic Article |
Why?
|
| Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. | Academic Article |
Why?
|
| The Bacterial Origins of the CRISPR Genome-Editing Revolution. | Academic Article |
Why?
|
| Precision cancer mouse models through genome editing with CRISPR-Cas9. | Academic Article |
Why?
|
| All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. | Academic Article |
Why?
|
| CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion. | Academic Article |
Why?
|
| A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing. | Academic Article |
Why?
|
| Development of Humanized Mice in the Age of Genome Editing. | Academic Article |
Why?
|
| Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing. | Academic Article |
Why?
|
| In vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency. | Academic Article |
Why?
|